Trademark: 97163732
Word
EPIGENALYTICS
Status
Dead
Status Code
602
Status Date
Wednesday, April 5, 2023
Serial Number
97163732
Mark Type
4000
Filing Date
Thursday, December 9, 2021
Abandoned Date
Wednesday, March 22, 2023

Trademark Owner History

Classifications
5 Testing kits comprised of medical diagnostic reagents and assays for testing for environmental and chemical toxins; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Autoimmune Diseases, Chronic Fatigue, Chronic Fatigue Syndrome, Myalgic Encephalitis or ME, and Fibromyalgia, Complex Chronic Illness, Gut Dysbiosis and Microbiome Disturbance, Inflammatory Bowel Disorders, Mold Illness, Mycotoxicosis, Degenerative Neurological Disorders, MS, ALS, MND, PD, Alzheimer's, Lewy Body Dementia, Neuropsychiatric Illnesses, PANDAS, PANS, Acute and Chronic Lyme Disease, genetic diseases, chronic illnesses, cancer, "aging" and other diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for use in the fields of genetics, epigenetics and toxicology; Diagnostic kits comprised of medical diagnostic reagents and assays for detecting substances having the potential for or affecting genetic expression, epigenetic expression; Diagnostic kits comprised of medical diagnostic reagents and assays for testing DNA and RNA and mitochondria
44 Medical diagnostic testing and reporting services; Medical analysis for the diagnosis and treatment of persons
10 Blood collection kits comprised of blood sample collection tubes and vials; medical sample tubes and vials for collecting blood samples; Biosensors for use in environmental safety and testing; biosensors for use in disease detection, namely, Autoimmune Diseases, Chronic Fatigue Chronic Fatigue Syndrome, Myalgic Encephalitis or ME and Fibromyalgia, Complex Chronic Illness, Gut Dysbiosis and Microbiome Disturbance, Inflammatory Bowel Disorders, Mold Illness, Mycotoxicosis, Degenerative Neurological Disorders, MS, ALS, MND, PD, Alzheimer's, Lewy body dementia, Neuropsychiatric Illnesses, PANDAS, PANS, Acute and Chronic Lyme Disease, genetic diseases, chronic illnesses, cancer, "aging" and other diseases; biosensors for diagnostic use in the fields of genetics, epigenetics and toxicology; biosensors for detecting substances having the potential for or affecting genetic expression, epigenetic expression; biosensors for testing DNA and RNA and mitochondria; Medical apparatus and instrument for testing for environmental and chemical toxins; Medical apparatus and instrument for testing of bodily fluids for use in disease detection, namely, Autoimmune Diseases, Chronic Fatigue Chronic Fatigue Syndrome, Myalgic Encephalitis or ME and Fibromyalgia, Complex Chronic Illness, Gut Dysbiosis and Microbiome Disturbance, Inflammatory Bowel Disorders, Mold Illness, Mycotoxicosis, Degenerative Neurological Disorders, MS, ALS, MND, PD, Alzheimer's, Lewy Body Dementia, Neuropsychiatric Illnesses, PANDAS, PANS, Acute and Chronic Lyme Disease, genetic diseases, chronic illnesses, cancer, "aging" and other diseases; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of genetics, epigenetics and toxicology; medical apparatus and instrument for detecting substances having the potential for or affecting genetic expression, epigenetic expression; Medical diagnostic apparatus for testing DNA and RNA and mitochondria

Trademark Events
Apr 5, 2023
Abandonment Notice E-Mailed - Failure To Respond
Apr 5, 2023
Abandonment Notice Mailed - Failure To Respond
Apr 5, 2023
Abandonment - Failure To Respond Or Late Response
Feb 23, 2023
Withdrawal Of Attorney Granted
Feb 23, 2023
Teas Withdrawal Of Attorney Received
Feb 23, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 23, 2023
Teas Change Of Correspondence Received
Feb 23, 2023
Teas Change Of Owner Address Received
Sep 21, 2022
Notification Of Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action E-Mailed
Sep 21, 2022
Non-Final Action Written
Sep 18, 2022
Assigned To Examiner
Dec 14, 2021
New Application Office Supplied Data Entered
Dec 13, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24